Arthritis, rheumatoid Trials in San Miguel de Tucumán, Argentina
Conditions / Arthritis, rheumatoid / San Miguel de Tucumán, Argentina
Clinical trials for Arthritis, rheumatoid investigate a range of treatment strategies and patient populations.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01606761 | A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) | COMPLETED | PHASE3 |
| NCT01856309 | Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 | COMPLETED | PHASE3 |
| NCT03970837 | Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) | TERMINATED | PHASE3 |
| NCT01682512 | Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis | TERMINATED | PHASE3 |
| NCT00113308 | COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT02092467 | Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis | COMPLETED | PHASE4 |
| NCT00261976 | A Long-term Safety Study of Infliximab (Remicade) | COMPLETED | — |
| NCT00689728 | A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy | COMPLETED | PHASE2 |
| NCT04333147 | Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) | TERMINATED | PHASE3 |
| NCT00973479 | An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy | COMPLETED | PHASE3 |